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a Department of Psychology, Norwegian University of Science and Technology, Trondheim, Norway 
b Department of Psychology, University of Tromsø, 9037 Tromsø, Norway 
c Karolinska Institutet, Novum, S-141 01 Hudddinge, Sweden   








A B S T R A C T   
Masculinization and feminization of rat sexual behavior has been supposed to occur during a short postnatal 
period. However, much data have made it evident that these processes may continue until adolescence. In the 
present study, we evaluated whether androgen treatment of females from postnatal day 20 and onwards could 
alter sexual motivation and behavior in a male direction. Juveniles were ovariectomized on day 20 and 
concurrently implanted with Silastic capsules containing either testosterone or dihydrotestosterone. Controls 
were implanted with an empty capsule. Tests for sexual incentive motivation and male sexual behavior were 
performed every fifth day when the females were between 50 and 75 days of age. At day 80, a test for female 
sexual behavior was performed. Females treated with testosterone approached a female sexual incentive far more 
than a male incentive, showing that sexual motivation had been changed in a male-like direction. Dihy-
drotestosterone had a similar, albeit smaller, effect. Females implanted with an empty capsule approached both 
incentives equally. Testosterone produced a high level of mounting behavior, whereas intromission-like 
behavioral patterns were rare and ejaculation-like behavior was absent. In the test for female sexual behavior, 
the testosterone-treated animals displayed a relatively high lordosis quotient, far above that displayed in females 
implanted with dihydrotestosterone or an empty capsule. It is concluded that treatment with an aromatizable 
androgen during the peripubertal-adolescent period masculinizes sexual motivation and partly sexual behavior. 
A non-aromatizable androgen weakly masculinize sexual motivation without enhancing male sexual behavior. It 
appears that simultaneous actions on androgen and estrogen receptors are needed for significant masculinization 
during the period studied here. Since the testosterone-treated females displayed lordosis, sexual behavior was not 
defeminized. In sum, these results suggest that sexual differentiation continues well into the peripubertal and 
adolescent periods.   
1. Introduction 
Some individuals are attracted to and engage in sexual behavior with 
members of their own sex, while others are attracted to the opposite sex. 
The factors that determine the preference for the same sex have fasci-
nated scientists for a long time, whereas the causes of preference for the 
opposite sex have been largely ignored. However, studies in rodents 
have suggested that gonadal hormones determine both kind of prefer-
ences. Originally, it was thought that these hormones have an organi-
zational effect on the central nervous system in such a way that perinatal 
exposure to androgens or estrogens masculinizes future sexual behavior 
whereas the absence of gonadal hormones will lead to female sexual 
behavior when adult (reviewed in [1]). In males, aromatization of 
testicular androgens within target areas in the brain appears to be 
essential for masculinization (reviewed in [2]). The locally produced 
estrogens act on the estrogen receptor α (ERα), whereas actions at the 
estrogen receptor β (ERβ) are not needed [3]. 
In females, gonadal hormones were considered unnecessary for 
feminization of brain and behavior. However, ovariectomy on postnatal 
day 1 leads to reduced paracopulatory behaviors in hormone-primed 
females at a series of tests starting when the females were 90 days old 
[4]. Likewise, females treated with the estrogen receptor antagonist 
tamoxifen on postnatal days 1 – 5 show reduced sexual behavior when 
treated with estradiol (E) + progesterone (P) as adults [5]. Furthermore, 
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mice lacking aromatase display reduced female sexual behavior and do 
not approach olfactory stimuli from a sexually active male [6]. E 
treatment between postnatal days 15 and 25 restored behavior, whereas 
treatment between postnatal days 5 and 15 did not [7]. There are also 
data showing that perinatal treatment with testosterone (T) or E cause 
permanent defeminization, whereas treatment with the 
non-aromatizable androgen DHT does not [8-13]. In sum, the role of 
neonatal gonadal hormones for feminization of adult sexual behavior 
does not seem to be entirely clear. 
Data concerning masculinization of females are contradictory. For 
example, E administered shortly after birth enhances male behavior 
patterns in adulthood [10, 11] and produces a preference for 
approaching other females [13]. However, lack of effect of early E 
treatment has also been reported [12]. Likewise, the effects of perinatal 
T treatment on masculinization of females are conflicting. Some studies 
report enhanced mounting (e.g. [14, 15]) whereas others fail to find an 
effect of perinatal T (e.g. [16, 17]). Thus, the effects of neonatal treat-
ment with E or T on masculinization in female rats are as unclear as 
those on feminization. One possible explanation for the conflicting re-
sults reported may be that neonatal hormone exposure is not enough 
neither for masculinization nor for feminization. Indeed, several obser-
vations suggest that the organizational actions of gonadal hormones 
may extend into the peripubertal period and perhaps even later. 
In female rats, the onset of puberty is generally marked by vaginal 
opening, occurring between postnatal days 32 and 34. This event is 
associated with the first ovulation, and consequently with high levels of 
estrogens (reviewed in [18]). The period following puberty, ranging 
between 35 and 60 days of age, has been named adolescence [19, 20]. It 
is characterized by profound neurobiological and behavioral changes (e. 
g. [21]), and may be considered a kind of sensitive period ([22] and 
references therein). Indeed, steroid hormones are involved in structural 
modifications in brain areas important for sexual behavior during 
adolescence [23]. The consequences of this for sexual behavior has been 
evaluated in only a handful of studies. 
The absence of ovarian hormones during the peripubertal and 
adolescent periods does not seem to affect sexual behavior in female 
rats. Ovariectomized females given E from postnatal day 30 until day 90 
were not different from control females when tested for female sexual 
behavior after a period of T treatment. However, in tests with a sexually 
receptive female as partner, the group treated with E during puberty and 
adolescence showed a far higher frequency of mounting and 
intromission-like behaviors than controls. In tests for sexual approach 
behavior, these females approached other females more than they 
approached males [24]. Thus, peripubertal and adolescent exposure to E 
masculinized sexual behaviors without any associated defeminization. 
The effects of administration of androgens during the peripubertal- 
adolescent period in female rats on T-induced, adult sexual behavior 
has not been evaluated. In the present experiment, we ovariectomized 
females on postnatal day 20 and simultaneously we initiated treatment 
with T. This treatment continued for the entire experiment. Tests for 
sexual approach behavior and for male as well as female copulatory 
behavior were performed between postnatal days 50 and 80. 
Considering that T is easily aromatized to E, we added a group 
treated with the highly potent, but non-aromatizable, androgen dihy-
drotestosterone (DHT). This allowed us to determine whether specific 
stimulation of the androgen receptor has effects similar to the simulta-
neous stimulation of estrogen and androgen receptors brought about by 
T. This experiment will determine whether peripubertal – adult T 
treatment can masculinize or defeminize female rat sexual behavior. 
2. Materials and methods 
2.1. Animals 
Male and female Wistar Han IGS rats (about 350 g and 250 g upon 
arrival, respectively) were purchased from Charles River (Sulzfeld, 
Germany). They were housed in same-sex pairs in Macrolon IV cages in a 
room with an inverted light/dark cycle (lights on 23 – 11). The tem-
perature was 21 ± 1 ◦C and relative humidity was 50 ± 10%. Com-
mercial rat pellets and tap water were available ad libitum. Some males 
and females were used for breeding, whereas others were used as 
copulation partners or sexual incentives. The males were left intact, 
while the latter females were ovariectomized under isoflurane anes-
thesia about two weeks before being used. They were given estradiol 
benzoate (EB), 25 µg/rat about 48 h prior to test, and progesterone, 1 
mg/rat, about 4 h before. Maximum receptivity and proceptivity at the 
time of testing was thereby assured. This experiment was approved by 
the Norwegian Food Safety Authority (ID5510) and animal care was in 
agreement with the European Union council directive 2010/63/EU. 
2.2. Procedure 
About two weeks after arrival, breeding was initiated. One female 
and three males were put together for one week. The males were then 
removed, and the female was observed daily. In case of signs of preg-
nancy, nesting material was provided. The litter was left with the mother 
until weaning on postnatal day 20. On that day, the female juveniles 
were ovariectomized under isoflurane anesthesia. In conjunction with 
the ovariectomy, 10 females were implanted with a 20 mm long, empty 
Silastic capsule (medical grade Silastic tubing, 1.6 mm inner diameter, 
3.2 mm outer diameter, Degania Silicone, Degania Bet, Israel), 9 females 
with a similar capsule filled with T, and 8 females received two 20 mm 
long capsules filled with DHT. Wounds were closed with surgical clips. 
The females were given postoperative buprenorphine, 0.05 mg/kg 
subcutaneously, every 12 h for 72 h. The male juveniles were used in 
other experiments. 
Silastic capsules of the size used here maintain the accessory sexual 
glands in castrated, adult males in a state similar to that found in intact 
males [25]. In that sense they can be assumed to produce serum con-
centrations of T and DHT within the physiological range. The capsules 
have been shown to maintain a rather stable serum level of T for more 
than two months [26], i.e. for the entire duration of the present study. 
Likewise, DHT-filled capsules maintain the integrity of the accessory 
sexual glands in castrated rats for at least 24 weeks [27], suggesting 
serum concentrations within the physiological range. However, in the 
juvenile females used in the present study, the hormone levels produced 
by these capsules must be entirely outside of that range. This is un-
problematic, since the purpose of this experiment was to determine 
whether these androgens could modify sexual differentiation in females 
during the peripubertal and adolescent periods. We will make no claim 
whatsoever that they may do so in physiological condition. This is a 
study of endocrine engineering, not of regular endocrine functions. 
After ovariectomy and capsule implantation, the females were 
housed in pairs until postnatal day 45. From then and until the end of the 
experiment, they were housed singly. The animals were weighed every 
10th day throughout the entire experiment. 
Tests for sexual incentive motivation were performed every 5th day, 
from postnatal day 50 until postnatal day 75. The testing arena and 
procedure have been described in detail elsewhere [28, 29]. Briefly, the 
test environment consists of an oval arena (100 × 50 cm) with 45 cm 
high walls. In the long walls there are two diagonally opposed openings 
covered with a double wire mesh. Behind the wire mesh, an incentive 
animal, inaccessible to the subject in the arena, was located. Incentives 
in this experiment were an intact male and a sexually receptive female. 
Although no physical contact was possible between the incentive ani-
mals and the experimental subject, they could see, hear and smell each 
other. At the beginning of a test, the subject was placed in the middle of 
the arena. A videotracking system (Ethovision, Noldus, Wageningen, the 
Netherlands) determined the subject’s position. A virtual area of 21 ×
29 cm was defined in front of each of the two openings. The video-
tracking system determined the time spent in each of these areas 
(incentive zones) and the number of visits to them. It also calculated the 
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distance moved during the test, the time spent moving, and the mean 
velocity of movement while moving. Each test lasted 10 min. The setup 
was located in a dimly lit room. Light intensity on the bottom of the 
arena was 1 lx. 
Immediately after the sexual incentive motivation test, the experi-
mental animals were transferred to a different room for observation of 
copulatory behavior. The experimental female was placed in a rectan-
gular steel sheet cage (40 × 60 cm, 40 cm high) with Plexiglas front. The 
floor was covered with wood shavings. Five min later, a sexually 
receptive female was introduced. Male behavior patterns performed by 
the experimental female were recorded. Mounts were counted only 
when pelvic thrusting was present. Intromission-like behavior was 
identified by the intense forward thrust at the end of a thrusting train, 
immediately followed by a forceful backward movement. Even though 
behavior patterns similar to male ejaculation have been described in 
females [30, 31], no such behavior was observed in the present study. 
The mount latency (time from the introduction of the stimulus female 
until first mount displayed by the experimental female was also recor-
ded. The test lasted for 30 min. 
An additional test for copulatory behavior was made on postnatal 
day 80. Here, the partner was a sexually experienced male rather than a 
female as was the case in the earlier tests. This male had been allowed to 
perform one intromission with another female immediately before the 
test. This female was then withdrawn from the observation cage and 
replaced by an experimental female. A different male was used for each 
female. Female behavior patterns (lordosis, paracopulatory behaviors 
and rejections) were recorded until the female had received 10 mounts 
(including mounts associated with intromission). The time the male 
needed to complete the ten mounts was also recorded. This time may 
depend on the female’s attractivity as much as on male vigor. 
2.3. Data preparation and statistical analysis 
Besides the variables recorded in the sexual incentive motivation 
test, we calculated the preference score (time spent with the female 
incentive / (time spent with the male incentive + time spent with the 
female incentive)). A score of 0.5 indicates that the female subject spent 
the same time with both incentives, whereas a score above 0.5 means a 
preference for the female incentive, and a score below 0.5 means a 
preference for the male incentive. The one-sample t-test was used for 
evaluating whether the observed preference score differed from 0.5, i.e. 
no preference. We also calculated the mean preference score obtained 
over the six tests. This score was analyzed with a one factor ANOVA with 
treatment as factor. The mean time spent with the incentives over the six 
tests was analyzed with two-factor ANOVA with treatment as between- 
subjects factor and sex of the incentive as within-groups factor. In 
addition, we analyzed the preference score at each of the six tests, the 
distance moved during the test, the time moving and the velocity of 
movement at each of the six tests with two-factor ANOVAs with repeated 
measures on one factor. The within-subjects factor was test (1 to 6) and 
the between-groups factor was treatment (empty capsule, T and DHT). 
Body weight was analyzed in a similar way. The time spent with the 
incentives and the number of visits to them at each test were analyzed 
with three-factor ANOVAs with repeated measures on two factors. The 
within-groups factors were incentive (male, female) and test (1 to 6) and 
the between groups factor was treatment (empty, T, DHT). In case of 
significant omnibus test, post hoc comparisons were made with Tukey’s 
HSD test. Tests for simple main effects were used after significant 
interactions. 
The proportion of animals displaying mounts and intromissions at 
each of the six tests for masculine copulatory behavior was analyzed by 
the chi-square test. The Bonferroni correction was used to protect p- 
values. After significant results, post hoc comparisons were made with 
Fisher’s exact test. The number of mounts and intromissions at each test 
was analyzed by the Kruskal-Wallis ANOVA with Bonferroni correction. 
This procedure was also used for evaluating the lordosis quotient (the 
number of lordosis displayed / the number of mounts received), para-
copulatory behaviors and rejections in the test for female copulatory 
behavior. It was also used for analyzing the time needed by the male to 
perform the ten required mounts. After a significant result, pairwise 
comparisons were made with Dunn’s test, with p-values adjusted with 
the Bonferroni correction. A p-value, adjusted when appropriate, below 
0.05 was considered significant. 
3. Results 
3.1. Body weight 
As can be seen in Fig. 1, the treatments had no effect on body weights 
(F2,24 = 0.233, p = 0.794). Not surprisingly, the age of the animals had a 
substantial effect (F4,96) = 1752.90, p < 0.001). More important, the 
growth was similar after all treatments, manifested as a non-significant 
interaction between day and treatment (F8,96 = 1.12, p = 0.359). 
3.2. Sexual incentive motivation 
In order to consider treatment effects on sexual incentive motivation 
to be functionally significant, it is necessary to find both increased 
preference score and an increase in the time spent with the corre-
sponding incentive. An increased preference score may be the result 
either of reduced time spent with one of the incentives or increased time 
spent with the other incentive, or a mixture of both. An increased score 
can be interpreted as enhanced motivation only if caused by an increase 
in the time spent with one of the incentives. An increased score based on 
reduced time spent with one of the incentives cannot be interpreted as 
an indication of increased sexual motivation. It should rather be inter-
preted as increased aversion. However, an increase in time spent with 
one of the incentives is not sufficient by itself. It could be due to an 
increase in sociability, i.e. simultaneous increase in time spent with both 
incentives. To rule out these alternative explanations, both the prefer-
ence score and the time spent with the sexual incentive must be 
enhanced in order to propose that sexual motivation was increased. 
More extensive discussion of the interpretation of data from the sexual 
incentive motivation test has been presented elsewhere [32, 33]. 
There was a significant main effect of treatment on the mean pref-
erence score (F2,24 = 13.82, p < 0.001). The Tukey HSD test showed that 
all groups differed, with the lowest score found in the group implanted 
with an empty capsule. Then followed the DHT group, while the highest 
Fig. 1. Body weight from day 20 to 70 in female rats ovariectomized at post-
natal day 20 and concurrently implanted with an empty Silastic capsule 
(Empty), a capsule filled with T or capsules filled with DHT. Weight data from 
postnatal day 40 were lost. Data are mean ± SEM. 
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score was found in the T group. The score obtained in the empty capsule 
group did not differ from 0.5 (t9 = 1.059, p = 0.317), meaning that the 
experimental females distributed their time equally between the male 
and female incentive. In the DHT group, the preference score was above 
0.5 (t7 = 3.414, p = 0.011). Consequently, the females in this group 
preferred the female incentive over the male. This was also the case in 
the T group (t8 = 12.186, p < 0.001). Data are shown in Fig. 2. 
When analyzing the data from each of the six tests, we found a sig-
nificant main effect of test on the preference score (F5,120 = 2.927, p =
0.016). However, comparisons between all tests with the Tukey HSD test 
failed to detect any difference. Nevertheless, as illustrated in supple-
mentary Fig. 1, the preference score was low in all groups at the test 
performed on postnatal day 50. In later tests, the score oscillated around 
0.5 in the group implanted with an empty capsule whereas it was 
consistently high in the T-group. The DHT group was intermediate at all 
tests. Consequently, the interaction test x treatment was non-significant 
(F10,120 = 0.488, p = 0.895). 
Turning to the time spent with the incentives, ANOVA showed that 
there was no main effect of treatment (F2,24 = 1.28, p = 0.296). The main 
effect of incentive was significant (F1,24 = 49.653, p < 0.001), as was the 
interaction treatment x incentive (F2,24 = 11.622, p < 0.001). Tests for 
simple main effects of incentive within each treatment revealed that the 
females implanted with an empty capsule spent equal time close to the 
male and female incentive (F1,24 = 0.703, p = 0.411) while the T-treated 
females spent more time with the female incentive than with the male 
incentive (F1,24 = 55.34, p < 0.001). This was also the case with the 
DHT-treated females (F1,24 = 14.39, p = 0.001). These results are 
illustrated in Fig. 3. 
We then analyzed the data from each test. There was no effect of test 
(F5,120 = 1.907, p = 0.098) and the interactions test x treatment, test x 
incentive and test x incentive x treatment were all non-significant (all ps 
> 0.100). This becomes evident upon examination of supplementary 
Fig. 2, in which data from each test and treatment are shown. 
The mean number of visits to the incentive was unaffected by 
treatment (F2,24 = 1.301, p = 0.291). However, there was a difference 
between incentives (F1,24 = 15.905, p = 0.001). When comparing the 
male and female incentive in each treatment with the Tukey HSD test it 
was found that the females implanted with an empty capsule made an 
equal number of visits to the male and female incentive (p = 0.406) 
while those implanted with T or DHT containing capsules made more 
visits to the female than to the male incentive (p = 0.001 and p = 0.014, 
respectively). These data are illustrated in Fig. 4. Supplementary Fig. 3 
shows the number of visits to each of the incentives at each of the six 
tests. The tests differed (F10,120 = 4.639, p = 0.001) whereas the in-
teractions treatment x incentive (F2,24 = 1.354, p = 0.277), treatment x 
test (F10,120 = 1.904, p = 0.051) and test x incentive (F5,120 = 0.347, p =
0.884) turned out to be non-significant. This was also the case for the 
three-factor interaction test x incentive x treatment (F10,120 = 0.975, p =
0.469). 
3.3. Ambulatory activity 
The hormone treatments did not affect any of the measures of 
ambulatory activity. Data and statistics are shown in Supplementary 
Fig. 4. 
3.4. Copulatory behavior 
The proportion of females displaying mounts differed between the 
Fig. 2. Preference score average from the six tests for sexual incentive moti-
vation performed between postnatal days 50 and 75 in female rats implanted 
with an empty Silastic capsule (Empty), a capsule filled with T or capsules filled 
with DHT. A preference score of 0.5 indicates no preference, whereas a score 
above 0.5 indicates preference for the female incentive. Data are mean ± SEM. 
+, the female incentive preferred over the male, p < 0.05; +++, p < 0.001. #, 
different from empty capsule, p < 0.001. ⌘, different from empty capsule and T, 
p < 0.05. 
Fig 3. Mean ± SEM time spent with the incentives in female rats implanted 
with an empty Silastic capsule (Empty), a capsule filled with T or capsules filled 
with DHT. Average of the 6 tests. ***, different from the time spent in the male 
incentive zone in the same treatment, p < 0.001. 
Fig. 4. Mean ± SEM number of visits to the incentives in female rats implanted 
with an empty Silastic capsule (Empty), a capsule filled with T or capsules filled 
with DHT. Average of the 6 tests. *, different from the number of visits to the 
male incentive zone in the same treatment, p < 0.05; ***, p < 0.001. 
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groups at all tests (chi-square values, all with df = 2, uncorrected p- 
values: Test at 50 days, 13.25, p = 0.001; test at 55 days, 20.67, p <
0.001; test at 60 days, 24.66, p < 0.001; test at 65 days, 21.03, p < 0.001; 
test at 70 days, 24.66, p < 0.001; test at 75 days, 21.03, p < 0.001; 
critical value for Bonferroni corrected p is 0.008). It was always larger in 
the T-group than in the group implanted with an empty capsule whereas 
there was no difference between the latter and the DHT-group according 
to the Fisher test. At the test performed on day 50, there was no dif-
ference between the females treated with T and DHT. However, these 
groups differed at all subsequent tests (see Fig. 5A). The number of 
mounts also differed between groups at all tests (values of Kruskal- 
Wallis H with 2 degrees of freedom, uncorrected p-values: Test at 50 
days, 12.10, p = 0.002; test at 55 days, 17.28, p < 0.001; test at 60 days, 
27.00, p < 0.001; test at 65 days, 22.74, p < 0.001; test at 70 days, 27.00, 
p < 0.001; test at 75 days, 26.54, p < 0.001; Bonferroni corrected critical 
p-value is 0.008). Dunn’s test revealed that the number of mounts was 
larger in the T-group than in the group implanted with an empty capsule 
at all tests. However, there was no difference between the T- and DHT- 
groups at the test on day 50, although these groups differed at all later 
tests. Data are shown in Fig. 5B. 
Even though most females in the T-group displayed mounts, few 
females in the group implanted with an empty capsule (one female 
mounted once in one of the six tests) and in the DHT-group (one female 
mounted in two tests, two females mounted in one of the tests) did so. 
Since the mount latency could be recorded only for mounting females, 
statistical between-groups comparison would not be meaningful. 
The proportion of females displaying the intromittive behavior 
pattern did not vary significantly between groups after the Bonferroni 
correction had been applied. In fact, only 33% of the females ever dis-
played intromission-like behavior (data not shown). 
The test for female copulatory behavior performed on postnatal day 
80 showed that the treatments differed with regard to LQ (H2 = 18.63, p 
< 0.001) and the number of paracopulatory behaviors (H2 = 10.22, p =
0.006) displayed during the test (Fig. 6A and 6 B). Post hoc tests 
revealed that the group treated with T had higher LQ and showed more 
paracopulatory behaviors than the other groups. There was no differ-
ence between the groups implanted with an empty capsule and that 
implanted with DHT-filled capsules. The number of rejections (H2 =
4.38, p = 0.112) as well as the time needed for receiving 10 mounts (H2 
= 0.20, p = 0.905) were unaffected by treatment; Figs. 6C and D). 
4. Discussion 
T treatment from weaning to adulthood made the females prefer to 
approach another female rather than a sexually active male. Considering 
that T is easily aromatized to E, and that treatment with E during the 
peripubertal-adolescent period also causes a preference for the female 
[24], this observation is not surprising. What might be surprising is the 
fact that DHT also made the females prefer to approach another female, 
albeit somewhat less than after treatment with T. This shows that 
stimulation of androgen receptors without any concomitant actions at 
estrogen receptors can masculinize sexual preferences in females. When 
DHT was given to adult, ovariectomized females, no effect on sexual 
approach behaviors could be detected [34, 35]. It appears, then, that 
exposure to DHT during the peripubertal and adolescent periods is 
necessary for effects of this steroid in the adult female. 
Contrary to the lack of effect of DHT treatment in adult females, T 
causes a robust approach to a male in such females [34, 36]. In fact, T is 
as efficient as E. Furthermore, the effects of T were much reduced by 
concurrent administration of the estrogen antagonist MER-25. It was 
concluded that T needs to be aromatized to E before affecting female 
sexual approach behaviors [34]. These observations show that treat-
ment with T limited to the adult period has effects completely opposite 
to those seen after peripubertal – adolescent treatment in the way that 
the former leads to a preference for approaching a male whereas the 
latter leads to a preference for other females. Consequently, the effects of 
T as well as those of DHT on sexual approach behaviors found in the 
present study must be attributed to actions during the 
peripubertal-adolescent period. 
The data reported here imply that T and DHT have an organizational 
effect far beyond the neonatal period. The activational effect, i.e. the 
actions of these hormones in the adult, presumably already organized 
brain, is determined by their prior organizational actions. Therefore, the 
effect of T and DHT in our females is opposite to that found in females 
not exposed to these androgens during peripuberty – adolescence, as 
mentioned in the preceding paragraph. 
It might be interesting to compare the sexual incentive motivation 
shown by the females in the present study to that normally shown by 
males. Although we did not run a group of males as part of the present 
experiment, we have a substantial amount of data from males collected 
in exactly the same setup as used here. The preference score in intact 
male rats ranges from 0.65 – 0.78 (see, e.g. [25, 28, 37, 38]). The mean 
score observed in the T-treated females in the present experiment was 
0.66 ± 0.01 (mean ± SEM), i.e. close to the low range of intact males. 
Castrated males wearing a DHT-implant of the same size as our females 
had a score of 0.62 [25] whereas our DHT-treated females had a score of 
0.59 ± 0.02 (mean ± SEM). All preference scores mentioned here were 
associated with a corresponding increase in the time spent with the 
sexual incentive. It appears that both T and DHT have effects of about 
the same magnitude in our females as they have in males, reinforcing the 
notion that peripubertal – adolescent treatment masculinizes adult 
Fig. 5. Male copulatory behavior in female rats implanted with an empty 
Silastic capsule (Empty), a capsule filled with T or capsules filled with DHT at 
each of six tests performed between postnatal days 50 and 75. A. Proportion of 
females displaying mounts. B. Number of mounts. *, different from empty, p <
0.05; #, different from DHT, p < 0.05. Data are mean ± SEM. 
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approach behavior. 
Comparisons of male copulatory behavior between males and fe-
males are difficult because fundamental aspects of this behavior, like 
intromission and ejaculation, were extremely rare in our females, 
probably because of the lack of a penis. The only reasonably frequent 
male behavior pattern observed in the present study was mounting in 
the T-treated females. This behavior was displayed with a latency of 198 
± 60 s, which is far above what is normally observed in males. In our 
testing conditions, castrated males implanted with a T capsule of the 
same size as used in the females, have a mount latency of 21 s. Even 
though a statistical comparison would be inappropriate, it seems safe to 
conclude that male copulatory behavior in our females was less 
masculinized than sexual incentive motivation. 
DHT affected neither male nor female copulatory behavior despite 
the fact that it stimulated approach to other females. This pattern of 
effect is quite similar to what we earlier observed in male rats, castrated 
as adults and then treated with DHT. These males approached a sexually 
receptive female more than they approached another male, yet they 
displayed almost no sexual behavior [25]. Incidentally, it can also be 
mentioned that these males approached the female incentive less than 
males treated with T, exactly as was the case with the females in the 
present experiment. It appears that the effects of DHT in females exposed 
to this androgen during the peripubertal-adolescent period is very 
similar to the effects seen in adult males. Therefore, we propose that 
sexual approach behavior had been masculinized by 
peripubertal-adolescent DHT treatment. It must also be pointed out that 
sexual approach behaviors are controlled by mechanisms somewhat 
different from those controlling copulatory behavior. For example, there 
is no correlation between the intensity of approach and intensity of 
copulation, and some drugs may affect one of these processes without 
altering the other (see [39] for an extensive discussion). The fact that 
DHT-treated females approach other females without copulating with 
them is just another example of this partial independence. 
T stimulated mounting of other females, coincident with its effects on 
sexual approach to the female incentive. There are many reports of T- 
stimulated mounting in adult female rats (e.g. [40] and references 
therein). When low doses of T are used, mounting is stimulated without 
any concurrent stimulation of lordosis behavior, and lordosis may be 
enhanced by E without any concurrent effect on mounting [41]. In the 
present study, T enhanced receptivity as well as mounting. Furthermore, 
a substantial amount of paracopulatory behaviors were displayed by the 
T-treated females. This is remarkable, since these behaviors are only 
displayed after rather high doses of estradiol. When low doses of 
estradiol are used, progesterone is needed for the display of para-
copulatory behavior [42, 43]. Thus, the fact that the complete female 
copulatory behavior pattern was shown by the T-treated females in the 
absence of progesterone clearly demonstrates that the peripubertal – 
adolescent hormone treatment did not defeminize copulatory behavior. 
There are many studies showing that large doses of T in adult females 
efficiently stimulates female copulatory behavior (e.g. [44, 45]), prob-
ably because of aromatization. Indeed, there are data showing that the 
effect of T can be blocked by estrogen receptor antagonists [46, 47] or an 
aromatase inhibitor [48]. As is often the case in the field, there are also 
contradictory observations. The aromatase inhibitor fadrozole failed to 
reduce the stimulatory effect of T on Fos responses in sexually relevant 
brain structures [49]. There are also older data suggesting a role for the 
androgen receptor in female sexual behavior. Long-term treatment with 
large doses of DHT stimulated lordosis in females ovariectomized as 
adults [50]. This effect was not replicated here, since DHT had no effect 
neither on male nor on female copulatory behavior patterns. It may also 
be mentioned that treatment with large doses of DHT around the same 
time as EB is given to ovariectomized females will lead to a considerable 
inhibition of lordosis behavior (e.g. [51, 52] and references therein). To 
the contrary, when DHT is given shortly before behavioral tests in EB 
primed females, lordosis is facilitated [53]. Thus, the effects of DHT on 
female sexual behavior are contradictory, ranging from stimulation 
Fig. 6. Female copulatory behavior in female rats implanted with an empty 
Silastic capsule (Empty), a capsule filled with T or capsules filled with DHT at a 
test performed when the females had reached an age of 80 days. A. LQ. B. 
Number of paracopulatory behaviors performed during the test. C. Number of 
rejections displayed during the test. *, different from empty and DHT, p < 0.05; 
**, p < 0.01. 
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through no effect to inhibition, depending on the timing of hormone 
administration, dose, and probably also on the age at which treatment 
was performed. 
A relevant question here is whether unmanipulated females ever are 
exposed to the amounts of DHT employed in the studies mentioned 
above. We have already manifested that the amount used in the present 
study is far above any possible physiological level. Nevertheless, the 
enzyme responsible for DHT production, 5α–reductase, is widely 
distributed in the brain of females, and there is no sex difference [54]. 
However, the serum T concentration is far lower in females than in 
males (e.g. [55, 56]), thereby limiting the availability of substrate for 
the 5α-reductases in females. Despite the modest T concentration in 
females, the concentration of DHT in hypothalamic tissue is similar in 
males and females during the period between 20 and 60 days of age 
[57]. Even though actions of DHT at central androgen receptors may be 
of limited importance in the female, this hormone has been shown to 
enhance the expression of 5α-reductase. This enzyme is necessary for the 
production of 5α-reduced progesterone derivatives [58, 59], some of 
which have been shown to affect female sexual behavior [see [60] and 
references therein). Whether such actions of DHT have any importance 
for the results reported here is uncertain, but it would be premature to 
exclude the possibility that DHT has some physiological function in 
females. 
The present study shows that DHT, in supraphysiological doses, 
somewhat affects female sexual motivation. Perhaps prolonged over-
production of DHT, due to some pathological condition, could alter the 
direction of female sexual preferences. In fact, DHT implant into female 
rats on postnatal day 21 has become a rodent model of the polycystic 
ovary syndrome in women [61]. This shows that DHT has effects in fe-
male reproductive organs, at least. Although this model is extensively 
used [62], no data concerning sexual motivation in these DHT treated 
female rats have been reported. However, sexual dysfunction is more 
common in infertile women diagnosed with the polycystic ovary syn-
drome than in women suffering infertility from other causes [63]. 
Desire, arousal, orgasm and lubrication were all reduced. Insofar as the 
polycystic ovary syndrome may be associated with elevated androgen 
production starting already before puberty and continuing even during 
menopause [64-66], these observations suggest that androgen exposure 
during a period similar to the one in the present study may have adverse 
effects in humans. Another study found that women diagnosed with 
polycystic ovary syndrome are more attracted to other women than 
healthy controls are [67]. This observation coincides with the results of 
the present study. 
5. Conclusion 
Present data show that treatment with T or DHT from postnatal day 
20 and on leads the female to prefer to approach another female rather 
than a male. Sexual approach behavior was masculinized. Since T was 
more efficient than DHT, it may be concluded that the simultaneous 
action at both estrogen and androgen receptors is more efficient than 
isolated action on the androgen receptor. Copulatory behavior was 
masculinized since abundant mounts were displayed, but not defemi-
nized because lordosis also was displayed. The LQ was quite high, 
particularly when considering that no progesterone was administered. 
These observations show that exposure to androgens long after the 
neonatal period changes female rat sexual behavior in a male direction. 
It is most important to note that the females were exposed to substantial 
amounts of androgens during the post-weaning, peripubertal and 
adolescent periods. Similar amounts could never be found in unmanip-
ulated females. Here we report what androgens can do to females during 
this period, not what they are normally doing. 
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